Axi-cel in CNS Lymphoma

Clinical trial NCT04608487 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04608487
Sponsor: Dana-Farber Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Lymphoma Cns

Start date: 2020-12-04
Primary completion: 2025-06-14
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.